ReCor Medical Announces Results from Landmark RADIANCE-HTN TRIO Study, Showing Clinically Significant Blood Pressure Reduction with the Paradise Ultrasound RDN System in Patients with Resistant Hypertension ...Middle East

PALO ALTO, Calif., May 16, 2021 /PRNewswire/ -- ReCor Medical, Inc. ("ReCor"), a wholly-owned subsidiary of Otsuka Medical Devices Co., Ltd., today presented the primary endpoint data from the randomized sham-controlled RADIANCE-HTN TRIO ("TRIO") study. In subjects with resistant...

Hence then, the article about recor medical announces results from landmark radiance htn trio study showing clinically significant blood pressure reduction with the paradise ultrasound rdn system in patients with resistant hypertension was published today ( Sunday 16/05/2021 - 07:46 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( ReCor Medical Announces Results from Landmark RADIANCE-HTN TRIO Study, Showing Clinically Significant Blood Pressure Reduction with the Paradise Ultrasound RDN System in Patients with Resistant Hypertension )

Also on site :

• Water Bill Rate Hike Map: Where 300,000 Could Pay Hundreds More in Missouri
• A Nostalgic Childhood Fave Is Dropping a New Lineup of Functional Beverages
• Blazers’ Splitter on Dundon reports: ‘Trying to be a pro’